Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depression

Introduction Selective serotonin reuptake inhibitors (SSRIs) and dual serotonin and noradrenaline reuptake inhibitors (SNRIs) are the most commonly prescribed class of antidepressants, yet it is not known whether one is superior to another. Aims The purpose of this clinical practice was to compare t...

Full description

Saved in:
Bibliographic Details
Published in:Human psychopharmacology 2003-08, Vol.18 (6), p.479-482
Main Authors: Morishita, Shigeru, Arita, Seizaburo
Format: Article
Language:English
Subjects:
Antidepressive Agents - therapeutic use
Bipolar Disorder - drug therapy
Cyclopropanes - therapeutic use
depression
Depressive Disorder, Major - drug therapy
Female
fluvoxamine
Fluvoxamine - therapeutic use
Humans
Male
Middle Aged
milnacipran
onset
Outpatients - statistics & numerical data
paroxetine
Paroxetine - therapeutic use
Psychiatric Status Rating Scales
Retrospective Studies
Time Factors
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Selective serotonin reuptake inhibitors (SSRIs) and dual serotonin and noradrenaline reuptake inhibitors (SNRIs) are the most commonly prescribed class of antidepressants, yet it is not known whether one is superior to another. Aims The purpose of this clinical practice was to compare the periods of onset of action of fluvoxamine, paroxetine and milnacipran. Methods A retrospective cohort analysis was carried out among out‐patients with depression treated in the Department of Psychiatry, Kawasaki Medical School Hospital, Kurashiki, Japan, in 2000 and 2001. A total of 206 patients receiving fluvoxamine, paroxetine and milnacipran were identified. Results The cumulative percentage of responders receiving milnacipran reached over 80% after 4 weeks, but it did reach this level for fluvoxamine or paroxetine until after 6 weeks. Conclusions The differential period of onset of action should help guide clinicians in determining a suitable duration of antidepressants for depression. Copyright © 2003 John Wiley & Sons, Ltd.
ISSN:0885-6222
1099-1077
DOI:10.1002/hup.508